StockNews.AI

Advanced Sterilization Products (ASP) Announces CE Mark for ULTRA GI™ Cycle for Duodenoscopes in Partnership with FUJIFILM Healthcare Europe

StockNews.AI • 4 hours

ASPFUJIFILM
High Materiality8/10

Information

New cycle for the STERRAD™ 100NX Sterilizer expands sterilization options, enhances reprocessing con...

Original source

AI Summary

ASP, a division of Fortive, has achieved CE mark approval for the ULTRA GI Cycle, enhancing patient safety in duodenoscope sterilization. This innovation, in partnership with FUJIFILM Healthcare, is expected to improve clinical confidence and market positioning, benefiting both existing and new medical facilities in Europe.

Sentiment Rationale

The CE mark approval signifies a credible product advancement, likely leading to increased sales in a growing market. Historical examples show product innovations often boost stock prices, especially in healthcare sectors.

Trading Thesis

FTV is set to see upward movement as the ULTRA GI Cycle gains traction, likely in the short term.

Market-Moving

  • CE mark approval enhances ASP's competitive positioning in European healthcare.
  • New partnerships with FUJIFILM could increase market share in sterilization technology.
  • Existing customers upgrading to ULTRA GI Cycle may boost ASP's revenue short-term.
  • Improved patient safety standards can elevate FTV's brand reputation and sales.

Key Facts

  • Fortive's ASP secures CE mark for ULTRA GI Cycle, enhancing patient safety.
  • The ULTRA GI Cycle improves sterilization for duodenoscopes using hydrogen peroxide technology.
  • Partnership with FUJIFILM Healthcare allows compatibility with new duodenoscope models.
  • Existing STERRAD 100NX users can upgrade to access the new cycle's benefits.
  • ASP aims to transform duodenoscope reprocessing safety in European healthcare.

Companies Mentioned

  • Fortive Corporation (FTV): ASP's new technology solidifies Fortive's position in healthcare.
  • FUJIFILM Healthcare Europe GmbH (FUJIFILM): Collaboration enhances product compatibility and market reach.

Corporate Developments

The announcement falls under 'Corporate Developments' as it highlights a significant technological advancement that can transform existing product lines and improve safety in healthcare, indicating strong growth potential in that niche market.

Advanced Sterilization Products (ASP) Receives CE Mark for ULTRA GI™ Cycle in Collaboration with FUJIFILM Healthcare Europe

ASP GmbH, a division of Fortive Corporation (NYSE: FTV), has announced the receipt of the CE mark approval for its latest innovation, the ULTRA GI™ Cycle. This advancement represents a significant evolution in sterilization practices for duodenoscopes, enhancing patient safety and reprocessing confidence across healthcare facilities.

Significance of the ULTRA GI™ Cycle

The ULTRA GI™ Cycle is designed for use with the STERRAD™ 100NX Sterilizer, which features ALLClear™ Technology. This innovative cycle addresses the complex challenges associated with traditional reprocessing methods, ultimately paving the way for improved infection control in medical environments.

“This is a meaningful step forward in our mission to make duodenoscope reprocessing safer across Europe,” stated Chad Rohrer, President of ASP. He emphasized that the integration of hydrogen peroxide gas plasma sterilization into standard procedures allows clinicians to devote more attention to patient care.

Partnerships and Future Plans

ASP aims to collaborate with medical device manufacturers to ensure that upcoming duodenoscope models are compatible with hydrogen peroxide sterilization systems. This partnership with FUJIFILM Healthcare Europe exemplifies ASP's commitment to enhancing patient safety and clinical practices.

  • The new FUJIFILM duodenoscope models ED-840T and ED-840XT will be integrated into the ULTRA GI Cycle.
  • Current STERRAD 100NX Sterilizer users can upgrade their cycle configuration to access ULTRA GI Cycle benefits.

Implications for Infection Control

According to Ivan Salgo, MD, Vice President and Chief Medical Officer at ASP, duodenoscopes have consistently presented challenges in infection control due to their high contamination rates. However, the new sterilization approach developed through the ASP and FUJIFILM partnership exceeds existing industry standards, providing healthcare professionals with cutting-edge solutions to enhance patient safety.

Additional Information

For more details about the ULTRA GI™ Cycle and its benefits, please visit the official webpage.

For media inquiries, contact:

  • Nuno Azeredo, Vice President, Global Brand Marketing, ASP - [Email not provided]
  • Christina Jones, Vice President, Investor Relations, Fortive Corporation - [Email not provided]

About Advanced Sterilization Products (ASP)

Advanced Sterilization Products (ASP) has been a leader in the design and delivery of innovative infection prevention solutions. With a history of raising healthcare safety standards, ASP's technologies are integral to the operations of medical facilities globally, allowing healthcare practitioners to prioritize infection prevention and patient care.

Related News